Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-03

Clinical Trial Update: The Efficacy of YiQiFuMai Injection as an Adjunctive Treatment for Sepsis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating YiQiFuMai Injection as an adjunctive treatment for sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • YiQiFuMai Injection

Snippet

Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences | Conditions: Sepsis | Phase 4 | Status: UNKNOWN